We are live on ! Find out more
CPXX

CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX

Delisted

CPXX was delisted on the 11th of July, 2016.

119 hedge funds and large institutions have $944M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2016 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more call options, than puts

Call options by funds: $95M | Put options by funds: $21.4M

342% more capital invested

Capital invested by funds: $214M → $944M (+$731M)

258% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 24

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

105% more funds holding

Funds holding: 58119 (+61)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

Holders
119
Holders Change
+61
Holders Change %
+105.17%
% of All Funds
3.17%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
86
Increased
21
Reduced
10
Closed
24
Calls
$95M
Puts
$21.4M
Net Calls
+$73.6M
Net Calls Change
+$74.3M
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
51
Wolverine Asset Management
Illinois
$3.25M +$2.19M +107,748 New
SMC
52
S. Muoio & Co
New York
$3.16M +$2.12M +104,600 New
TCIM
53
TIAA CREF Investment Management
New York
$2.85M +$1.91M +94,332 New
CS
54
Credit Suisse
Switzerland
$2.66M +$1.79M +88,087 New
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$2.65M
PAM
56
Panagora Asset Management
Massachusetts
$2.18M +$1.47M +72,289 New
CCM
57
Chicago Capital Management
Illinois
$2.11M +$1.42M +70,000 New
California State Teachers Retirement System (CalSTRS)
58
California State Teachers Retirement System (CalSTRS)
California
$2.07M +$1.39M +68,493 New
Charles Schwab
59
Charles Schwab
California
$1.86M +$1.25M +61,600 New
KAM
60
Kassirer Asset Management
Ontario, Canada
$1.81M +$1.22M +60,000 New
Ameriprise
61
Ameriprise
Minnesota
$1.79M -$2.55M -125,544 -68%
AllianceBernstein
62
AllianceBernstein
Tennessee
$1.73M +$1.16M +57,200 New
HA
63
Havens Advisors
New York
$1.69M +$1.14M +56,128 New
KC
64
Kellner Capital
New York
$1.66M +$1.12M +55,100 New
OTC
65
Opera Trading Capital
France
$1.66M +$1.12M +55,000 New
Walleye Trading
66
Walleye Trading
New York
$1.61M +$1.04M +51,089 +2,221%
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
$1.58M -$1.48M -73,092 -58%
TA
68
Teachers Advisors
New York
$1.58M +$1.06M +52,271 New
Swiss National Bank
69
Swiss National Bank
Switzerland
$1.51M +$1.02M +50,100 New
VOAM
70
Vertex One Asset Management
British Columbia, Canada
$1.37M +$923K +45,500 New
Bank of America
71
Bank of America
North Carolina
$1.36M -$394K -19,402 -30%
IA
72
IndexIQ Advisors
New York
$1.17M +$787K +38,780 New
State of Wisconsin Investment Board
73
State of Wisconsin Investment Board
Wisconsin
$1.14M +$763K +37,600 New
Creative Planning
74
Creative Planning
Kansas
$1.09M +$732K +36,068 New
AL
75
Airain Ltd
Guernsey
$1.08M +$723K +35,640 New

CPXX Hedge Fund Activity: Q2 2016 in Review

119 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q2 2016, worth a combined $944M — up 342% from $214M a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new CPXX positions and 24 closed out — a net gain of 62 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was Alpine Associates Management, opening a new position worth an estimated $45M. The largest seller was Visium Asset Management, exiting entirely with an estimated $16M sold.

  • 119 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q2 2016, up from 58 in Q1 2016.
  • Funds reported $944M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q2 2016, up 342% quarter-over-quarter.
  • 86 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q2 2016 and 24 closed out, a net change of +62 holders.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q2 2016 was Alpine Associates Management, an estimated $45M added.
  • The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q2 2016 was Visium Asset Management, an estimated $16M sold.

Based on aggregated 13F filings for Q2 2016.